Menu

Editas Medicine, Inc. EDIT

Full chart Compare
Set alert

Price alert · EDIT

All alert types
2.57 USD +0.02 (+0.78%)

At closeNov 6, 2026, 6:37 PM EST

2.57 0.00 0.00%

After hours · Nov 6, 6:37 PM ET

2.48 Day range 2.63
1.66 52-week range 3.75
YTD
+25.37%
1 year
-4.46%

Discussion (212)

Sign in to join the discussion

Vivian O'Neal EDIT 6 years ago #61

I think that was the spark that this group needed as well. It is off to the races. This is the beginning of a nice move

Vivian O'Neal EDIT 6 years ago #62

It is about time this group got the spotlight. It’s been almost a decade since discovery and clinical data is trickling in. Definitely do not want to wait until the trial results are completed to get in. The majority of the move will be missed

Vivian O'Neal EDIT 6 years ago #63

How true that is we have to be grateful that we are the .001 that are here before the masses. I ALSO TIP MY HAT TO Smart money like ARK BLACKROCK AND VANGUARD

Vivian O'Neal EDIT 6 years ago #65

Let the shorts he shorts they had their chance to make money last 6 weeks. This looks to be a clear reversal and beginning of nice move to upside

Vivian O'Neal EDIT 6 years ago #66

CRISP wants new high hope edit will follow. I hope we all know Jen was cofounder of EDIT and left after six months to start NTLA

Vivian O'Neal EDIT 6 years ago #67

I do not like the fact that EDIT is lagging the group. CRSP and BEAM are within reach of 52 week highs while we struggle to get back to the 50dma not cool. These guys need to get with it

Vivian O'Neal EDIT 6 years ago #68

The IP dominated by Editas and Broad Institute is worth much more then the Nobel Prize. That is like giving Cardi B a Grammy when you know someone else wrote her lyrics.